These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 3294920)

  • 21. Amoxapine as an antipsychotic: comparative study versus haloperidol.
    Chaudhry IB; Husain N; Khan S; Badshah S; Deakin B; Kapur S
    J Clin Psychopharmacol; 2007 Dec; 27(6):575-81. PubMed ID: 18004123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of warm-supplementing kidney yang (WSKY) capsule added on risperidone on cognition in chronic schizophrenic patients: a randomized, double-blind, placebo-controlled, multi-center clinical trial.
    Chen ZH; Wang GH; Wang XP; Chen RY; Wang HL; Yang MH; Huo YX; Mei HB
    Hum Psychopharmacol; 2008 Aug; 23(6):465-70. PubMed ID: 18536066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Double-blind study on the therapy of postural hypotension in psychotic patients under psychotropic medication (author's transl)].
    Volk W; Stoll KD
    Arzneimittelforschung; 1976; 26(6):1188-9. PubMed ID: 786317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluspirilene: a long-acting injectable neuroleptic.
    Drug Ther Bull; 1977 Jul; 15(15):59-60. PubMed ID: 330126
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pathomorphology of the brains of schizophrenic patients treated with psychotropic drugs (concerning drug pathomorphosis)].
    Kuznetsova VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(7):929-33. PubMed ID: 465163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of treatment of various forms of schizophrenia in the light of a 5-year follow-up].
    Rydzyński Z; Górski H; Stańczyk JL; Tokarz S
    Psychiatr Pol; 1978; 12(5-6):549-54. PubMed ID: 724848
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical laboratory test standards in new drug trials.
    Holden JM; Itil T; Simeon J; Fink M
    J Clin Pharmacol J New Drugs; 1967; 7(1):1-8. PubMed ID: 4951237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hypotonic disorders of circulation regulation caused by therapy with psychotropic drugs. Treatment with 9alpha-fluorhydrocortisone].
    Volk W
    Med Welt; 1977 Nov; 28(45):1853-4. PubMed ID: 593126
    [No Abstract]   [Full Text] [Related]  

  • 29. Fluspirilene in the treatment of non-hospitalized schizophrenic patients.
    Soni SD
    Curr Med Res Opin; 1977; 4(9):645-9. PubMed ID: 590024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A therapeutic study of an adamantane spiro compound in experimental influenza A infection in man.
    Arroyo M; Beare AS; Reed SE; Craig JW
    J Antimicrob Chemother; 1975 Dec; 1(4 Suppl):87-93. PubMed ID: 1107299
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessment of drugs in schizophrenia. Discussion on basic trial design.
    Coppen A
    Br J Clin Pharmacol; 1976 Jun; 3(3 Suppl 2):381-3. PubMed ID: 791325
    [No Abstract]   [Full Text] [Related]  

  • 32. [Letter: Schizophrenic psychiatry].
    Jacobowsky B
    Lakartidningen; 1975 May; 72(21):2243. PubMed ID: 1128120
    [No Abstract]   [Full Text] [Related]  

  • 33. Ambulatory activity during treatment with fluspirilene in chronic schizophrenics.
    Perris C; Rapp W
    Acta Psychiatr Scand Suppl; 1974; 249():117-22. PubMed ID: 4608470
    [No Abstract]   [Full Text] [Related]  

  • 34. Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors.
    Leysen JE; Janssen PM; Schotte A; Luyten WH; Megens AA
    Psychopharmacology (Berl); 1993; 112(1 Suppl):S40-54. PubMed ID: 7530377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A controlled clinical trial of tiaspirone in schizophrenia.
    Jain AK; Kelwala S; Moore N; Gershon S
    Int Clin Psychopharmacol; 1987 Apr; 2(2):129-33. PubMed ID: 2885367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of antipsychotic activity of an unique agent: SU-23397.
    Mielke EH; Gallant DM; Bishop G; Kessler CM
    Psychopharmacol Commun; 1975; 1(2):117-22. PubMed ID: 4858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.
    Buckley PF
    Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aripiprazole: new drug. Just another neuroleptic.
    Prescrire Int; 2005 Oct; 14(79):163-7. PubMed ID: 16285069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tiaspirone in schizophrenia.
    Moore NC; Meyendorff E; Yeragani V; LeWitt PA; Gershon S
    J Clin Psychopharmacol; 1987 Apr; 7(2):98-101. PubMed ID: 3294920
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.